American cutaneous leishmaniasis: In situ immune response of patients with recent and late lesions

Abstract

TNF-α, IFN-γ, IL-10, IL-17, CD68 and CD57 were evaluated in biopsies of patients with American cutaneous leishmaniasis living in Sorocaba, Brazil. The analyses were performed considering the time of lesions from 23 patients with recent lesions (Group I) and 19 patients with late lesions (Group II). All patients were infected with Leishmania (Viannia) braziliensis. Immunostaining cells for CD68, CD57, TNF- α, IFN-γ, IL-10 and IL-17 were performed by immunohistochemistry. Except for CD68 and IL-17, the distribution of in situ for CD57, IL-10, TNF-α and IFN-γ showed that patients with recent lesions expressed higher levels than those with late lesions. The comparison of cytokine expression/group showed that IL-10 was significantly higher than IL-17 and IFN-γ (similar data were shown in IL-17 compared with TNF-α), suggesting an immunological balance between inflammatory-anti-inflammatory agents. This balance was similar for two groups of patients. In conclusion, these data suggested that (i) patients from Group I had recent lesions (in the beginning of chronic phase) compared to those from Group II and (ii) the modulation of inflammatory response in patients with recent American cutaneous leishmaniasis was correlated with IL-10 expression in skin lesions preventing the development of mucosal forms. The parasite treatment also prevented the evolution of severe forms.

An Epidemiological, Diagnostic, and Therapeutic Study of the Leishmania tropica Parasite in Iraq’s Anbar Province

“…The highest incidence of infection was recorded in the face, hands, and legs of the body which corresponds with a study Gomes et al (26). The reason for this is that these areas of the body are easily accessible and therefore most prone to bites of insects due to their exposure.…”

Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis

“…Leishmaniasis is one of the major neglected tropical diseases (NTD) that mainly affects the population of low‐income countries . The disease is categorized as cutaneous (CL), mucocutaneous (MCL) and visceral leishmaniasis (VL), which is caused by over 20 species of the Leishmania (L) parasites . Cutaneous leishmaniasis (CL) with an estimated incidence of 1.5‐2 million cases annually is the most prevalent form of leishmaniasis .…”

First case report of atypical disseminated cutaneous leishmaniasis in an opium abuser in Iran

“…Briefly, the cell mediated immunity (Th1) responses deviate into humoral immunity (Th2) via the cAMP dependent pathway, which eventually blocks Th1 cytokines expression such as TNF-α, IFN-γ, IL-10 and IL-5, raising Th2 cytokines expression 19 , 20 . Therefore, lower expressions of the Th1 cytokines cause the dissemination of the Leishmania parasites 14 , 21 . Moreover, some studies showed that alkaloid opioids induce immunosuppression and depress the cell function of natural killer (NK) and phagocytic cells; therefore causing dissemination of parasites to other parts on body 19 , 22 .…”